From EU-Startups
Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery
Samplix, a Danish BioTech company developing droplet microfluidics technology for functional single-cell analysis, has announced a €25 million first closing of a financing round. The financing compri...